Skip to main content



Local Cdiff information for Georgia

Georgia

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Georgia.



Local Cdiff information for Georgia

Georgia

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Georgia.

Providers

Nirja Mehta, MD, MS

Emory University Hospital Midtown Campus
550 Peachtree Street Northeast
Medical Office Tower, Fl 7
Atlanta, GA 30308

(404) 686-8114

VISIT WEBSITE>

 

Dr. Ravi Kamepalli, MD

Regional Infectious Diseases and Infusion Center, Inc.
505 Jenkins St
LaGrange, 30240
706-739-7789
FMT Provider: Yes
VISIT WEBSITE >

Dr. Colleen Kraft, MD Assistant Professor, Pathology & Laboratory Medicine

Emory Clinic at 1365 Clifton Road
1365 Clifton Road NE
Atlanta, 30322
404-686-8114
EMAIL DR. KRAFT >
FMT Provider: Yes
VISIT WEBSITE >

Michael H. Woodworth, MD, Infectious Disease Specialist

Grady Memorial Hospital, Ponce de Leon Center
341 Ponce De Leon Ave NE
Atlanta, GA 30308

404-616-1000
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 2203
Hospital Onset: 2203
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.67
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Jeanne Negley, MBA
HAI Surveillance Program Director
Georgia Department of Community Health
Division of Public Health Acute Disease Epidemiology Section
2 Peachtree Street NW, #14-225
Atlanta, 30303
(404) 657-2593
(404) 657-7517
EMAIL JEANNE NEGLEY, MBA >

CLINICAL TRIALS

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.

LMN-201

Official Title: A Phase 2, Randomized, Double-blind, Placebo-controlled Study of LMN-201 for Prevention of C. Difficile Infection Recurrence
Trial No. NCT05330182
Type: Interventional
Recruitment: Recruiting
Sponsor: Lumen Bioscience, Inc.
Contact: Carl Mason, MD
EMAIL >
Gender: All
Age: 18 Years and older

BEETHOVEN

Official Title: A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER
Trial No. NCT07282665
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: See trial website for site-specific contacts
Gender: All
Age: 65 Years and older

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

C. Difficile Toxin Levels Post-Antibiotic Treatment

Official Title: A Prospective, Observational Study to Evaluate C. Difficile Toxin Levels in Stool in Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI
Trial No. NCT07250724
Type: Observational
Recruitment: Recruiting
Sponsor: Bactolife A/S
Contact: Colleen S Kraft, MD
EMAIL: colleen.kraft@emory.edu
Gender: All
Age: 18 years to 75 years

PRISM

Official Title: A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above
Trial No. NCT07285213
Type: Interventional
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: See trial website for site-specific contacts
Gender: All
Age: 18 Years and older